William H. Sherman

6.0k total citations
85 papers, 4.0k citations indexed

About

William H. Sherman is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, William H. Sherman has authored 85 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 27 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in William H. Sherman's work include Peripheral Neuropathies and Disorders (29 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Multiple Myeloma Research and Treatments (10 papers). William H. Sherman is often cited by papers focused on Peripheral Neuropathies and Disorders (29 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Multiple Myeloma Research and Treatments (10 papers). William H. Sherman collaborates with scholars based in United States, Italy and France. William H. Sherman's co-authors include Norman Latov, Arthur P. Hays, Elliott F. Osserman, Lewis P. Rowland, Masami Takatsu, Robert E. Lovelace, Robert L. Fine, Audrey S. Penn, Leonard Chess and Vivette D. D’Agati and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

William H. Sherman

83 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Sherman United States 37 2.1k 943 931 809 670 85 4.0k
Janet M. Bruner United States 37 899 0.4× 759 0.8× 1.3k 1.4× 123 0.2× 1.7k 2.6× 97 4.2k
Chiaki Nakaseko Japan 31 625 0.3× 675 0.7× 776 0.8× 298 0.4× 765 1.1× 166 3.5k
Torsten Pietsch Germany 31 819 0.4× 466 0.5× 1.3k 1.4× 166 0.2× 1.5k 2.2× 78 3.4k
David W. Kimmel United States 31 1.3k 0.6× 639 0.7× 1.2k 1.3× 215 0.3× 1.9k 2.9× 50 3.8k
Masao Matsutani Japan 34 921 0.4× 655 0.7× 789 0.8× 174 0.2× 2.0k 3.0× 98 3.5k
Regina I. Jakacki United States 35 1.8k 0.8× 679 0.7× 969 1.0× 76 0.1× 2.3k 3.5× 94 4.0k
G M Brodeur United States 26 4.4k 2.1× 1.1k 1.1× 2.8k 3.0× 176 0.2× 625 0.9× 46 5.9k
David M. Loeb United States 39 266 0.1× 1.2k 1.3× 2.4k 2.6× 711 0.9× 150 0.2× 142 4.6k
Karen Pulford United Kingdom 27 737 0.3× 1.5k 1.6× 1.2k 1.3× 61 0.1× 700 1.0× 49 4.2k
Girish Dhall United States 31 942 0.4× 581 0.6× 1.2k 1.3× 78 0.1× 1.8k 2.7× 129 3.3k

Countries citing papers authored by William H. Sherman

Since Specialization
Citations

This map shows the geographic impact of William H. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Sherman more than expected).

Fields of papers citing papers by William H. Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Sherman. The network helps show where William H. Sherman may publish in the future.

Co-authorship network of co-authors of William H. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Sherman. A scholar is included among the top collaborators of William H. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Sherman. William H. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartemes, Kathleen R., Raymond M. Moore, Brenna C. Novotny, et al.. (2025). Increased Interaction between B Cells and CD3+ T Cells in Nonprogressors with Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma. Clinical Cancer Research. 31(9). 1719–1729.
2.
3.
Sherman, William H., et al.. (2015). Effect of Subtype of K-Ras Mutation on Survival in Resected Pancreatic Adenocarcinoma. JOP, journal of the pancreas. 16(6). 1 indexed citations
4.
Sherman, William H., et al.. (2015). Fludarabine in the Treatment of Refractory Chronic Inflammatory Demyelinating Neuropathies. Journal of Clinical Neuromuscular Disease. 17(1). 1–5. 6 indexed citations
5.
Gulati, Anthony P., Stephen M. Schreibman, Beth Schrope, et al.. (2014). Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).. Journal of Clinical Oncology. 32(3_suppl). 274–274. 2 indexed citations
6.
Sherman, William H., George Niedt, Bret Taback, et al.. (2013). An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. 69(4). 595–602.e1. 44 indexed citations
7.
8.
9.
Smith, Helen, Helen Smith, Helen Smith, et al.. (2011). Renaissance Paratexts. Cambridge University Press eBooks. 43 indexed citations
10.
Johnson, Hillary, William H. Sherman, & Désirée Ratner. (2010). Using Imatinib as Neoadjuvant Therapy in Dermatofibrosarcoma Protuberans: Potential Pluses and Minuses. Journal of the National Comprehensive Cancer Network. 8(8). 881–885. 12 indexed citations
11.
Kaufman, Howard L., Bret Taback, William H. Sherman, et al.. (2009). Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma. Journal of Translational Medicine. 7(1). 2–2. 55 indexed citations
12.
Sherman, William H.. (2003). Distant Relations: Letters from America, 1492-1677. Huntington Library Quarterly. 66. 225–245. 1 indexed citations
13.
Olsen, Sonja J., Karin Tarte, William H. Sherman, et al.. (1998). EXAMINATION OF KSHV INFECTION IN MULTIPLE MYELOMA PATIENTS. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A28–A28. 1 indexed citations
14.
Sherman, William H., et al.. (1993). Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells. Immunologic Research. 12(4). 338–348. 8 indexed citations
15.
Hays, Arthur P., Arthur P. Hays, Vivette D. D’Agati, et al.. (1990). A Monoclonal IgA in a Patient with Amyotrophic Lateral Sclerosis Reacts with Neurofilaments and Surface Antigen on Neuroblastoma Cells. Journal of Neuropathology & Experimental Neurology. 49(4). 383–398. 25 indexed citations
16.
Hays, Arthur P., Saud Sadiq, Vivette D. D’Agati, et al.. (1989). A MONOCLONAL IgAγ IN MOTOR NEURON DISEASE REACTS WITH NEUROFILAMENTS AND THE SURFACE OF NEUROBLASTOMA CELLS. Journal of Neuropathology & Experimental Neurology. 48(3). 364–364. 3 indexed citations
17.
Takatsu, Masami, Arthur P. Hays, Norman Latov, et al.. (1985). Immunofluorescence study of patients with neuropathy and IgM M proteins. Annals of Neurology. 18(2). 173–181. 91 indexed citations
18.
Nobile‐Orazio, Eduardo, et al.. (1983). Anti‐MAG IgM antibodies in patients with neuropathy and IgM M proteins. Neurology. 33(7). 939–939. 46 indexed citations
19.
Latov, Norman, et al.. (1983). Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: A Morphological study. Annals of Neurology. 14(1). 43–54. 16 indexed citations
20.
Osserman, Elliott F., et al.. (1982). Identical Twin Marrow Transplantation in Multiple Myeloma. Acta Haematologica. 68(3). 215–223. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet M. Bruner Breakdown of academic impact, for papers by Chiaki Nakaseko Breakdown of academic impact, for papers by Torsten Pietsch Breakdown of academic impact, for papers by David W. Kimmel Breakdown of academic impact, for papers by Masao Matsutani Breakdown of academic impact, for papers by Regina I. Jakacki Breakdown of academic impact, for papers by G M Brodeur Breakdown of academic impact, for papers by David M. Loeb Breakdown of academic impact, for papers by Karen Pulford Breakdown of academic impact, for papers by Girish Dhall
Rankless by CCL
2026